More precise diagnosis of access stenosis: ultrasonography versus angiography.
Patency of mature vascular access for hemodialysis is mostly limited by the growing stenoses leading to acute access thrombosis. The therapy of choice is usually percutaneous balloon angioplasty (PTA). However, PTA injures the vessel wall and subsequent re-stenosis develops faster than de novo stenosis. Therefore, the key is in appropriate timing of PTA procedures--as late as possible but before access thrombosis develops. Ultrasonography combines the morphologic and functional access assessment, but the former is less precise than angiography. The aim of this study was to compare ultrasonographic and angiographic measuring of residual diameter as the additional criterion of significant stenoses used in our center. Residual diameter of significant stenoses was measured by B-mode ultrasonography three times in 20 patients. All the patients were indicated for angiography and the residual diameter of the stenoses was re-analyzed by this method. The repeatability of ultrasonographic residual diameter measurements and reproducibility in comparison to angiography were expressed by coefficients of variation (CV). The residual diameter was 1.69 ± 0.05 mm by ultrasound and 1.65 ± 0.59 mm measured by angiography. In the ultrasound repeatability study, CV was 3.17 ± 2.76% and in the reproducibility study CV was 18.0 ± 15.6%. All the stenoses found to be significant by ultrasound were above 65% by angiography and PTA was performed. Ultrasonographic measurement of the residual diameter is stable in experienced hands and is well comparable to angiography results. These findings advocate residual diameter of 2.0 mm as the strong additional criterion of the significant stenoses, which can also be used in ultrasound surveillance of arteriovenous grafts.